203
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Optimal management of sarcomas of the breast: an update

, &

References

  • May DS, Stroup NE. The incidence of sarcomas of the breast among women in the United States, 1973-1986. Plast Reconstr Surg 1991;87(1):193-4
  • ESMO/ European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23(Suppl 7):vii92-9
  • Adem C, Reynolds C, Ingle JN, Nascimento AG. Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature. Br J Cancer 2004;91(2):237-41
  • McGowan TS, Cummings BJ, O’Sullivan B, et al. An analysis of 78 breast sarcoma patients without distant metastases at presentation. Int J Radiat Oncol Biol Phys 2000;46(2):383-90
  • Lahat G, Lazar A, Lev D. Sarcoma epidemiology and etiology: potential environmental and genetic factors. Surg Clin North Am 2008;88(3):451-81
  • Blanchard DK, Reynolds CA, Grant CS, Donohue JH. Primary nonphylloides breast sarcomas. Am J Surg 2003;186(4):359-61
  • Brady MS, Garfein CF, Petrek JA, Brennan MF. Post-treatment sarcoma in breast cancer patients. Ann Surg Oncol 1994;1(1):66-72
  • Kadouri L, Sagi M, Goldberg Y, et al. Genetic predisposition to radiation induced sarcoma: possible role for BRCA and p53 mutations. Breast Cancer Res Treat 2013;140(1):207-11
  • West JG, Weitzel JN, Tao ML, et al. BRCA mutations and the risk of angiosarcoma after breast cancer treatment. Clin Breast Cancer 2008;8(6):533-7
  • Bousquet G, Confavreux C, Magne N, et al. Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network. Radiother Oncol 2007;85(3):355-61
  • Fields RC, Aft RL, Gillanders WE, et al. Treatment and outcomes of patients with primary breast sarcoma. Am J Surg 2008;196(4):559-61
  • Gutman H, Pollock RE, Ross MI, et al. Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience. Surgery 1994;116(3):505-9
  • Pollard SG, Marks PV, Temple LN, Thompson HH. Breast sarcoma. A clinicopathologic review of 25 cases. Cancer 1990;66(5):941-4
  • Vorburger SA, Xing Y, Hunt KK, et al. Angiosarcoma of the breast. Cancer 2005;104(12):2682-8
  • Surov A, Holzhausen HJ, Ruschke K, Spielmann RP. Primary breast sarcoma: prevalence, clinical signs, and radiological features. Acta Radiol 2011;52(6):597-601
  • Yang WT, Hennessy BT, Dryden MJ, et al. Mammary angiosarcomas: imaging findings in 24 patients. Radiology 2007;242(3):725-34
  • Smith TB, Gilcrease MZ, Santiago L, et al. Imaging features of primary breast sarcoma. AJR Am J Roentgenol 2012;198(4):W386-93
  • Surgeons TASoB percutaneous needle biopsy for image detected breast abnormalities. Available from: www.breastsurgeons.org/statements/PDF_Statements/Percutaneous_Needle_Biopsy.pdf
  • Kumar R, Chauhan A, Vellimana AK, Chawla M. Role of PET/PET-CT in the management of sarcomas. Expert Rev Anticancer Ther 2006;6(8):1241-50
  • Pai M, Yoon SN. 18F-FDG imaging of the primary breast leiomyosarcoma and follow-up lung metastasis. Clin Nucl Med 2013;38(3):e152-4
  • Barrow BJ, Janjan NA, Gutman H, et al. Role of radiotherapy in sarcoma of the breast – a retrospective review of the M.D. Anderson experience. Radiother Oncol 1999;52(2):173-8
  • McGregor GI, Knowling MA, Este FA. Sarcoma and cystosarcoma phyllodes tumors of the breast – a retrospective review of 58 cases. Am J Surg 1994;167(5):477-80
  • Zelek L, Llombart-Cussac A, Terrier P, et al. Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up. J Clin Oncol 2003;21(13):2583-8
  • Jones MW, Norris HJ, Wargotz ES, Weiss SW. Fibrosarcoma-malignant fibrous histiocytoma of the breast. A clinicopathological study of 32 cases. Am J Surg Pathol 1992;16(7):667-74
  • Torres KE, Ravi V, Kin K, et al. Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer. Ann Surg Oncol 2013;20(4):1267-74
  • Tan PH, Ellis IO. Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO Classification of Tumours of the Breast 2012. J Clin Pathol 2013;66(6):465-70
  • National Comprehensive Cancer Network (NCCN) guidelines. Available from: www.nccn.org [Last accessed 10 October 2013]
  • Pollack R, Brennan M, Lawrence W Jr. Society of Surgical Oncology practice guidelines. Soft-tissue sarcoma surgical practice guidelines. Oncology (Williston Park) 1997;11(9):1327-32
  • Al-Benna S, Poggemann K, Steinau HU, Steinstraesser L. Diagnosis and management of primary breast sarcoma. Breast Cancer Res Treat 2010;122(3):619-26
  • Berg JW, Decrosse JJ, Fracchia AA, Farrow J. Stromal sarcomas of the breast. A unified approach to connective tissue sarcomas other than cystosarcoma phyllodes. Cancer 1962;15:418-24
  • Confavreux C, Lurkin A, Mitton N, et al. Sarcomas and malignant phyllodes tumours of the breast – a retrospective study. Eur J Cancer 2006;42(16):2715-21
  • Ilhan E, Vardar E, Ozkok G, et al. A rare tumour of the breast: carcinosarcoma. J Clin Med Res 2010;2(2):96-8
  • Toesca A, Spitaleri G, De Pas T, et al. Sarcoma of the breast: outcome and reconstructive options. Clin Breast Cancer 2012;12(6):438-44
  • de Jong MA, Oldenborg S, Bing Oei S, et al. Reirradiation and hyperthermia for radiation-associated sarcoma. Cancer 2012;118(1):180-7
  • Palta M, Morris CG, Grobmyer SR, et al. Angiosarcoma after breast-conserving therapy: long-term outcomes with hyperfractionated radiotherapy. Cancer 2010;116(8):1872-8
  • Riad S, Biau D, Holt GE, et al. The clinical and functional outcome for patients with radiation-induced soft tissue sarcoma. Cancer 2012;118(10):2682-92
  • Brennan M, Harrison L. Soft tissue sarcoma. In: DeVita V Jr, Hellman S, Rosenberg S, editors. Cancer: principles and practice of oncology. Lippincot Williams and Wilkins; Philadelphia, PA, USA: 2008. p. 1731-852
  • Hui A, Henderson M, Speakman D, Skandarajah A. Angiosarcoma of the breast: a difficult surgical challenge. Breast 2012;21(4):584-9
  • Blay JY. Trabectedin’s contribution to the treatment of sarcomas. Expert Rev Anticancer Ther 2013;13(6 Suppl 1):3-9
  • Wilky BA, Meyer CF, Trent JC. Pazopanib in sarcomas: expanding the PALETTE. Curr Opin Oncol 2013;25(4):373-8
  • Chen KT, Kirkegaard DD, Bocian JJ. Angiosarcoma of the breast. Cancer 1980;46(2):368-71
  • Christensen L, Schiodt T, Blichert-Toft M, et al. Sarcomas of the breast: a clinico-pathological study of 67 patients with long term follow-up. Eur J Surg Oncol 1988;14(3):241-7
  • Terrier P, Terrier-Lacombe MJ, Mouriesse H, et al. Primary breast sarcoma: a review of 33 cases with immunohistochemistry and prognostic factors. Breast Cancer Res Treat 1989;13(1):39-48
  • Monroe AT, Feigenberg SJ, Mendenhall NP. Angiosarcoma after breast-conserving therapy. Cancer 2003;97(8):1832-40
  • Sordillo PP, Chapman R, Hajdu SI, et al. Lymphangiosarcoma. Cancer 1981;48(7):1674-9
  • Marchal C, Weber B, de Lafontan B, et al. Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers. Int J Radiat Oncol Biol Phys 1999;44(1):113-19

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.